Latest Natera News & Updates

See the latest news and media coverage for Natera. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Natera

Cell-free DNA testing company

natera.com
Headquarters
Austin, United States
Founded year
2004
Company type
Public company
Number of employees
5,500–10,000
Industry
Biotechnology & Medical Research

Last updated

Latest news about Natera

In short: Natera achieved record 2025 revenue of $2.3 billion, secured FDA approval for its Signatera CDx test, and won major patent litigation.

Company announcements

Natera

Natera's Signatera receives regulatory approval in Japan for colorectal cancer

It is the first PMDA-approved MRD test in Japan for use in the adjuvant setting. Commercial launch expected by year-end.

Unlock all announcements with a

Media coverage

Yahoo Finance

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let's have a look at Natera (NASDAQ:NTRA...

Unlock all articles with a

Never miss news about Natera

Track Natera and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Natera competitors & trending companies

Browse news for competitors to Natera and other trending companies.